BHP Shares Fall as Jansen Potash Project Costs Surge 
Trump Says Anthropic No Longer Seen as National Security Threat 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
WILMINGTON, Del., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Vital Therapies, Inc. (NASDAQ:VTL)?
- Did you purchase your shares between April 17, 2014 and August 21, 2015, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. reminds shareholders of Vital Therapies, Inc. (“Vital Therapies” or the “Company”) (NASDAQ:VTL) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. A complaint was filed in the United States District Court for the Southern District of California on behalf of all persons or entities that purchased the common stock of Vital Therapies between April 17, 2014 and August 21, 2015, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you wish to serve as lead plaintiff, you must move the Court no later than February 1, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you purchased shares of Vital Therapies during the Class Period, or purchased shares prior to the Class Period and still hold Vital Therapies, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/vital-therapies-inc-vtl.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com
